In the News

1852 News Items found
DNA wrapped around histones
Decoder
What Is Epigenetics?
Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.
Three friends
Support
Memorial Sloan Kettering social workers Meredith Cammarata and Liz Blackler give advice to anyone who wants to offer support to someone they know with cancer.
Pictured: Ping Chi
In the Lab
Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.
Pictured: Scott Lowe
In the Lab
In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.
Pictured: Experimental Brain Tumor
In the Lab
Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.
MSK and Hartford leadership holding certificate
Announcement
The certification comes after a year in which hundreds of experts worked together to assess standards of care at Hartford HealthCare Cancer Institute.
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
In the Lab
Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.
Pictured: Johanna Joyce
In the Lab
A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.
Lab mouse with cultured human pluripotent stem cells
In the Lab
Memorial Sloan Kettering researchers have developed a powerful new way to study human disease using stem cells whose genomes can be manipulated at will.
An origami crane illustrates the importance of RNA folding for regulating gene translation. The bolded sequences on the crane’s wings indicate the portion that is critical for the manufacture of many cancer-causing proteins.
In the Lab
Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting <em>MYC</em>, a cancer-causing gene that has remained elusive until now.